Targeting PI3Kδ: Emerging Therapy for Chronic Lymphocytic Leukemia and Beyond

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-1128|35|4|720-752

ISSN： 0198-6325

Source： MEDICINAL RESEARCH REVIEWS, Vol.35, Iss.4, 2015-07, pp. : 720-752

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondria‐Targeting Polyamine–Protoporphyrin Conjugates for Photodynamic Therapy

By  

CHEMMEDCHEM, Vol. 13, Iss. 1, 2018-01 ,pp. : 15-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting Human C‐Type Lectin‐like Molecule‐1 (CLL1) with a Bispecific Antibody for Immunotherapy of Acute Myeloid Leukemia

By  

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 53, Iss. 37, 2014-09 ,pp. : 9841-9845

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting Human C‐Type Lectin‐like Molecule‐1 (CLL1) with a Bispecific Antibody for Immunotherapy of Acute Myeloid Leukemia

By  

ANGEWANDTE CHEMIE, Vol. 126, Iss. 37, 2014-09 ,pp. : 9999-10003

John Wiley & Sons Inc

Access to resources Recommend Favorite

3D Self‐Supporting Porous Magnetic Assemblies for Water Remediation and Beyond

By  

ADVANCED ENERGY MATERIALS (ELECTRONIC), Vol. 6, Iss. 17, 2016-09 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Size Changeable Nanocarriers with Nuclear Targeting for Effectively Overcoming Multidrug Resistance in Cancer Therapy

By  

ADVANCED MATERIALS, Vol. 27, Iss. 41, 2015-11 ,pp. : 6450-6456

John Wiley & Sons Inc

Access to resources Recommend Favorite